Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Subcutaneous infection model facilitates treatment assessment of secondary Alveolar echinococcosis in mice.

Küster T, Hermann C, Hemphill A, Gottstein B, Spiliotis M.

PLoS Negl Trop Dis. 2013 May 23;7(5):e2235. doi: 10.1371/journal.pntd.0002235. Print 2013.

2.

Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.

María AC, Celina EM.

Acta Trop. 2014 Dec;140:61-7. doi: 10.1016/j.actatropica.2014.08.007. Epub 2014 Aug 19.

PMID:
25149355
3.

In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes.

Spicher M, Naguleswaran A, Ortega-Mora LM, Müller J, Gottstein B, Hemphill A.

Exp Parasitol. 2008 Aug;119(4):475-82. doi: 10.1016/j.exppara.2008.02.012. Epub 2008 Mar 7.

PMID:
18442817
4.

In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.

Küster T, Stadelmann B, Hermann C, Scholl S, Keiser J, Hemphill A.

Antimicrob Agents Chemother. 2011 Feb;55(2):713-21. doi: 10.1128/AAC.01392-10. Epub 2010 Dec 6.

5.

Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.

Stadelmann B, Rufener R, Aeschbacher D, Spiliotis M, Gottstein B, Hemphill A.

PLoS Negl Trop Dis. 2016 Mar 11;10(3):e0004535. doi: 10.1371/journal.pntd.0004535. eCollection 2016 Mar.

6.

Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.

Abulaihaiti M, Wu XW, Qiao L, Lv HL, Zhang HW, Aduwayi N, Wang YJ, Wang XC, Peng XY.

PLoS Negl Trop Dis. 2015 Sep 9;9(9):e0003950. doi: 10.1371/journal.pntd.0003950. eCollection 2015.

7.

In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis.

Albani CM, Pensel PE, Elissondo N, Gambino G, Elissondo MC.

Vet Parasitol. 2015 Sep 15;212(3-4):193-9. doi: 10.1016/j.vetpar.2015.06.030. Epub 2015 Jul 10.

PMID:
26190130
8.

Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis.

Hemphill A, Spicher M, Stadelmann B, Mueller J, Naguleswaran A, Gottstein B, Walker M.

Parasitology. 2007 Nov;134(Pt 12):1657-70. Epub 2007 Jul 16. Review.

PMID:
17631693
9.

Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model.

Küster T, Stadelmann B, Aeschbacher D, Hemphill A.

Int J Antimicrob Agents. 2014 Apr;43(4):335-42. doi: 10.1016/j.ijantimicag.2014.01.013. Epub 2014 Feb 12.

PMID:
24646943
10.

Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions.

Ricken FJ, Nell J, Grüner B, Schmidberger J, Kaltenbach T, Kratzer W, Hillenbrand A, Henne-Bruns D, Deplazes P, Moller P, Kern P, Barth TFE.

PLoS Negl Trop Dis. 2017 May 25;11(5):e0005636. doi: 10.1371/journal.pntd.0005636. eCollection 2017 May.

11.

Treatment of echinococcosis: albendazole and mebendazole--what else?

Hemphill A, Stadelmann B, Rufener R, Spiliotis M, Boubaker G, Müller J, Müller N, Gorgas D, Gottstein B.

Parasite. 2014;21:70. doi: 10.1051/parasite/2014073. Epub 2014 Dec 22. Review.

12.

Molecular survival strategies of Echinococcus multilocularis in the murine host.

Gottstein B, Haag K, Walker M, Matsumoto J, Mejri N, Hemphill A.

Parasitol Int. 2006;55 Suppl:S45-9. Epub 2005 Dec 13. Review.

PMID:
16352460
13.

In vitro and in vivo activities of dicationic diguanidino compounds against Echinococcus multilocularis metacestodes.

Küster T, Kriegel N, Boykin DW, Stephens CE, Hemphill A.

Antimicrob Agents Chemother. 2013 Aug;57(8):3829-35. doi: 10.1128/AAC.02569-12. Epub 2013 May 28.

14.

Morphological changes of larval Echinococcus multilocularis in mice treated with albendazole or mebendazole.

Nakaya K, Oomori Y, Kutsumi H, Nakao M.

J Helminthol. 1998 Dec;72(4):349-54.

PMID:
9858633
15.

Echinococcus multilocularis alkaline phosphatase as a marker for metacestode damage induced by in vitro drug treatment with albendazole sulfoxide and albendazole sulfone.

Stettler M, Siles-Lucas M, Sarciron E, Lawton P, Gottstein B, Hemphill A.

Antimicrob Agents Chemother. 2001 Aug;45(8):2256-62.

16.

A Rapid and Convenient Method for in Vivo Fluorescent Imaging of Protoscolices of Echinococcus multilocularis.

Yang T, Wang S, Zhang X, Xia J, Guo J, Hou J, Zhang H, Chen X, Wu X.

Korean J Parasitol. 2016 Apr;54(2):225-31. doi: 10.3347/kjp.2016.54.2.225. Epub 2016 Apr 30.

17.

To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis.

Gorgas D, Marreros N, Rufener R, Hemphill A, Lundström-Stadelmann B.

Parasitology. 2017 Jun;144(7):937-944. doi: 10.1017/S0031182017000051. Epub 2017 Mar 8.

PMID:
28270242
18.

Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode.

Rodrigues JM Jr, Bories C, Emery I, Fessi H, Devissaguet JP, Liance M.

Int J Parasitol. 1995 Dec;25(12):1437-41.

PMID:
8719955
19.

Recurrent hepatic alveolar echinococcosis: report of the first case in Korea with unproven infection route.

Kim SJ, Kim JH, Han SY, Kim YH, Cho JH, Chai JY, Jeong JS.

Korean J Parasitol. 2011 Dec;49(4):413-8. doi: 10.3347/kjp.2011.49.4.413. Epub 2011 Dec 16.

20.

Alveolar echinococcosis in a Thai patient after migration to an endemic area in Central Europe.

Warnnissorn N, Uiprasertkul M, Atisook K, Sirivatanauksorn Y, Limawongpranee S.

Travel Med Infect Dis. 2006 Jan;4(1):34-7. Epub 2005 Jul 22. No abstract available.

PMID:
16887723

Supplemental Content

Support Center